Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease.

Kepe V, Ghetti B, Farlow MR, Bresjanac M, Miller K, Huang SC, Wong KP, Murrell JR, Piccardo P, Epperson F, Repovs G, Smid LM, Petric A, Siddarth P, Liu J, Satyamurthy N, Small GW, Barrio JR.

Brain Pathol. 2010 Mar;20(2):419-30. doi: 10.1111/j.1750-3639.2009.00306.x. Epub 2009 Jun 9.

PMID:
19725833
2.

Simplified parametric methods for [18F]FDDNP studies.

Yaqub M, Tolboom N, van Berckel BN, Scheltens P, Lammertsma AA, Boellaard R.

Neuroimage. 2010 Jan 1;49(1):433-41. doi: 10.1016/j.neuroimage.2009.07.046. Epub 2009 Jul 28.

PMID:
19643186
3.

Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies.

Yaqub M, Boellaard R, van Berckel BN, Tolboom N, Luurtsema G, Dijkstra AA, Lubberink M, Windhorst AD, Scheltens P, Lammertsma AA.

Mol Imaging Biol. 2009 Sep-Oct;11(5):322-33. doi: 10.1007/s11307-009-0208-1. Epub 2009 Apr 2.

4.

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

Shin J, Lee SY, Kim SH, Kim YB, Cho SJ.

Neuroimage. 2008 Nov 1;43(2):236-44. doi: 10.1016/j.neuroimage.2008.07.022. Epub 2008 Jul 23.

PMID:
18694837
5.

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.

Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe KL, Kung HP, Zhang W, Kung MP, Skovronsky D, Dyrks T, Holl G, Krause S, Friebe M, Lehman L, Lindemann S, Dinkelborg LM, Masters CL, Villemagne VL.

Lancet Neurol. 2008 Feb;7(2):129-35. doi: 10.1016/S1474-4422(08)70001-2. Epub 2008 Jan 10.

PMID:
18191617
6.

PET of brain amyloid and tau in mild cognitive impairment.

Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.

N Engl J Med. 2006 Dec 21;355(25):2652-63.

7.

High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) ready for animal or human administration.

Liu J, Kepe V, Zabjek A, Petric A, Padgett HC, Satyamurthy N, Barrio JR.

Mol Imaging Biol. 2007 Jan-Feb;9(1):6-16.

PMID:
17051324
8.

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X, Meltzer CC, Schimmel K, Tsopelas ND, DeKosky ST, Price JC.

J Nucl Med. 2005 Dec;46(12):1959-72.

9.

Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging.

Wu Y, Carson RE.

J Cereb Blood Flow Metab. 2002 Dec;22(12):1440-52.

PMID:
12468889
10.

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

Thal DR, Rüb U, Orantes M, Braak H.

Neurology. 2002 Jun 25;58(12):1791-800.

PMID:
12084879
11.

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.

Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, Cole GM, Small GW, Huang SC, Barrio JR.

J Neurosci. 2001 Dec 15;21(24):RC189.

12.

Simultaneous estimation of physiological parameters and the input function--in vivo PET data.

Wong KP, Feng D, Meikle SR, Fulham MJ.

IEEE Trans Inf Technol Biomed. 2001 Mar;5(1):67-76.

PMID:
11300218
13.

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

Price JL, Morris JC.

Ann Neurol. 1999 Mar;45(3):358-68.

PMID:
10072051
14.

Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease.

Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E.

J Nucl Med. 1998 Feb;39(2):293-8.

15.

Simplified reference tissue model for PET receptor studies.

Lammertsma AA, Hume SP.

Neuroimage. 1996 Dec;4(3 Pt 1):153-8.

PMID:
9345505
16.

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE.

Ann Neurol. 1997 Jul;42(1):85-94.

17.

Distribution volume ratios without blood sampling from graphical analysis of PET data.

Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL.

J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40.

PMID:
8784228
18.

Comparison of methods for analysis of clinical [11C]raclopride studies.

Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, Frackowiak RS.

J Cereb Blood Flow Metab. 1996 Jan;16(1):42-52.

PMID:
8530554
19.

Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data.

Logan J, Volkow ND, Fowler JS, Wang GJ, Dewey SL, MacGregor R, Schlyer D, Gatley SJ, Pappas N, King P, et al.

J Cereb Blood Flow Metab. 1994 Nov;14(6):995-1010.

PMID:
7929663

Supplemental Content

Support Center